- Companies
- Egepol Hastaneleri
Egepol Hastaneleri Valuation Multiples
Egepol Hastaneleri is valued at $71M as of September 2026, a 2.4x revenue multiple. In the last fiscal year, Egepol Hastaneleri revenue was $28M and Egepol Hastaneleri EBITDA was $4M.
Egepol Hastaneleri Overview
About Egepol Hastaneleri
Nasmed Ozel Saglik Hizmetleri Ticaret AS provides quality healthcare services. It arranges consultations, travel planning, accommodation, translation, and other relevant services for its patients 24/7.
Founded
2009
HQ
Employees
N/A
Website
Sectors
Financials (Last FY)
EV
$67M
Valuation Multiples
Start free trialEgepol Hastaneleri Financials
Egepol Hastaneleri reported last fiscal year revenue of $28M and EBITDA of $4M.
In the same fiscal year, Egepol Hastaneleri generated $4M in gross profit, $4M in EBITDA, and $55K in net income.
Egepol Hastaneleri P&L
In the most recent fiscal year, Egepol Hastaneleri reported revenue of $28M and EBITDA of $4M.
Egepol Hastaneleri is profitable as of last fiscal year, with gross margin of 16%, EBITDA margin of 13%, and net margin of 0%.
Financial data powered by Morningstar, Inc.
Egepol Hastaneleri Stock Performance
Egepol Hastaneleri has current market cap of $71M, and enterprise value of $67M.
Egepol Hastaneleri's stock price is $0.14.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $67M | $71M | -1.9% | - | - | - | $0.00 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialEgepol Hastaneleri Valuation Multiples
Egepol Hastaneleri trades at 2.4x EV/Revenue multiple, and 18.9x EV/EBITDA.
Egepol Hastaneleri Financial Valuation Multiples
As of September 24, 2026, Egepol Hastaneleri has market cap of $71M and EV of $67M.
Egepol Hastaneleri has a P/E ratio of 1310.7x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Egepol Hastaneleri Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Egepol Hastaneleri Margins & Growth Rates
In the most recent fiscal year, Egepol Hastaneleri reported gross margin of 16%, EBITDA margin of 13%, and net margin of 0%.
Egepol Hastaneleri Margins
Data powered by FactSet, Inc. and Morningstar, Inc.
Egepol Hastaneleri Operational KPIs
Data powered by FactSet, Inc. and Morningstar, Inc.
Egepol Hastaneleri Competitors
Egepol Hastaneleri competitors include Concord Medical, Giunti Psychometrics, FamiCord, Hyperfine, Lokman Hekim, One Health Group, Medcorp, EuroEyes Eye Clinic, Sudmedica and Clinica de Marly.
Most Egepol Hastaneleri public comparables operate across Hospitals & Clinics.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $69M | ($5M) | 7.7x | - | (103.4x) | - | |||
| $43M | $7M | 1.7x | - | 10.1x | - | |||
| $101M | $6M | 0.7x | 0.7x | 11.4x | 6.0x | |||
| $14M | ($36M) | 4.0x | 3.0x | (1.5x) | (1.7x) | |||
| $87M | $14M | 1.3x | - | 8.1x | - | |||
| $42M | $3M | 0.9x | 0.9x | 11.6x | 11.6x | |||
| - | - | - | - | - | - | |||
| $101M | $29M | 0.7x | - | 2.5x | - | |||
This data is available for Pro users. Sign up to see all Egepol Hastaneleri competitors and their valuation data. Start Free Trial | ||||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Egepol Hastaneleri
| When was Egepol Hastaneleri founded? | Egepol Hastaneleri was founded in 2009. |
| Where is Egepol Hastaneleri headquartered? | Egepol Hastaneleri is headquartered in Turkey. |
| Is Egepol Hastaneleri publicly listed? | Yes, Egepol Hastaneleri is a public company listed on Borsa Istanbul. |
| What is the stock symbol of Egepol Hastaneleri? | Egepol Hastaneleri trades under EGEPO ticker. |
| When did Egepol Hastaneleri go public? | Egepol Hastaneleri went public in 2021. |
| Who are competitors of Egepol Hastaneleri? | Egepol Hastaneleri main competitors include Concord Medical, Giunti Psychometrics, FamiCord, Hyperfine, Lokman Hekim, One Health Group, Medcorp, EuroEyes Eye Clinic, Sudmedica, Clinica de Marly. |
| What is the current market cap of Egepol Hastaneleri? | Egepol Hastaneleri's current market cap is $71M. |
| What is the current revenue of Egepol Hastaneleri? | Egepol Hastaneleri's last fiscal year revenue is $28M. |
| What is the current EV/Revenue multiple of Egepol Hastaneleri? | Current revenue multiple of Egepol Hastaneleri is 2.4x. |
| Is Egepol Hastaneleri profitable? | No, Egepol Hastaneleri is not profitable. |
| How many companies Egepol Hastaneleri has acquired to date? | Egepol Hastaneleri hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Egepol Hastaneleri has invested to date? | Egepol Hastaneleri hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Egepol Hastaneleri
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




